| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/28/2005 | US20050090536 Substituted pyrrol-3-ylisoxazoles, e.g., N-benzyl-4-[4-(o-chlorophenyl)-5-isoxazolyl)pyrrole-2-carboxamide; treating diseases that are alleviated by a protein kinase inhibitor, particularly cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 04/28/2005 | US20050090527 H1 antagonists used include loratadine, desloratadine, cetirizine and fexofenadine; H3 antagonists used include thioperamide, impromidine, burimamide, clobenpropit, impentamine, and mifetidine; and H4 antagonists used include dual H3/H4 antagonists |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050090519 1-Alkyl-4-(3-substitutedphenyl)piperidines |
| 04/28/2005 | US20050090513 Compounds specific to adenosine a1 and a3 receptors and uses thereof |
| 04/28/2005 | US20050090501 Heteroaryl-cyclic acetals |
| 04/28/2005 | US20050090494 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 04/28/2005 | US20050090491 2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/28/2005 | US20050090487 Cardiovascular disorders; antiinflammatory agents |
| 04/28/2005 | US20050089970 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089520 Antibody stimulating il-ira production |
| 04/28/2005 | US20050089517 for treating respiratory diseases: asthma, allergic rhinitis, atopic dermatitis, nasal polyposis, Churg-Strauss syndrome, sinusitis, and chronic obstructive pulmonary disease (COPD), administering an antibody (i,e Daclizumab) that binds specifically to an IL-2 receptor |
| 04/28/2005 | US20050089478 Formeratol and budesonide for treatment of respiratory system disorders such as chronc obstructive pulmonary disease |
| 04/28/2005 | US20050089477 Medicaments |
| 04/28/2005 | CA2542636A1 Muscarinic acetylcholine receptor antagonists field of the invention |
| 04/27/2005 | EP1526134A2 Triazolyl tropane derivatives as ccr5 modulators |
| 04/27/2005 | EP1525884A1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525313A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 04/27/2005 | EP1525204A1 Phenylalanine enamide derivatives |
| 04/27/2005 | EP1525201A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 04/27/2005 | EP1525200A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/27/2005 | EP1525191A2 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/27/2005 | EP1525180A2 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 04/27/2005 | EP1525018A1 Medicament dispenser |
| 04/27/2005 | EP1524997A1 Stable liquid parenteral parecoxib formulation |
| 04/27/2005 | EP1524980A1 Phenylalanine enamide derivatives containing a spiro[3.5]non-1-ene ring for use as integrin inhibitors |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1455799B1 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists |
| 04/27/2005 | EP1424996B1 Method for the production of inhalation powders |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1261327B1 Adenosine receptor modulators |
| 04/27/2005 | EP1144411B1 Antihistaminic spiro compounds |
| 04/27/2005 | EP0994853B1 A monoether of probucol and methods for the inhibition of the expression of vcam-1 |
| 04/27/2005 | EP0935470B1 Method for treating allergic lung disease |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN2694979Y Medicated plaster for treating nasitis |
| 04/27/2005 | CN1610751A Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 04/27/2005 | CN1610680A Process for preparing scopine esters |
| 04/27/2005 | CN1610674A Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 04/27/2005 | CN1610670A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/27/2005 | CN1610548A Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 04/27/2005 | CN1610542A New use for the treatment of gastroesophageal reflux disease |
| 04/27/2005 | CN1610502A Surfactant protein for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2005 | CN1609119A Peptide library, its synthesis process and active segment screened from the peptide library |
| 04/27/2005 | CN1609113A Effective cowberry part for treating respiratory tract disease and its prepn process |
| 04/27/2005 | CN1609105A 1-methylolimidazole [1, 2-alpha] quinoxaline compound and its application |
| 04/27/2005 | CN1608673A Prepn process of S190 polypeptide vaccine and its application in resisting SARS virus |
| 04/27/2005 | CN1608667A Cape jasmine buccal tablet and its prepn process |
| 04/27/2005 | CN1608654A Chinese medicine for treating intrapulmonic infection and SARS |
| 04/27/2005 | CN1608627A SARS preventing medicine |
| 04/27/2005 | CN1608619A Medicine recipe with baicalin |
| 04/27/2005 | CN1608615A Fibrauretine-amino acid fluid for transfusion and its production process |
| 04/27/2005 | CN1608613A Fibrauretine powder for injection and its production process |
| 04/27/2005 | CN1198932C Streptococcus pneumoniae antigens |
| 04/27/2005 | CN1198931C MOraxella catarrhalis BASB034 polypeptides and uses thereof |
| 04/27/2005 | CN1198841C Method for preparing cyclic vasoactive peptide analogs |
| 04/27/2005 | CN1198832C New amino propylphosphinic acid |
| 04/27/2005 | CN1198825C 8-pheyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives |
| 04/27/2005 | CN1198819C Benzimidazole derivatives |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198804C Amide compounds and use thereof |
| 04/27/2005 | CN1198592C Process for producing particles with converted amorphous and/or meta-stable drystalline region into crystalline state |
| 04/27/2005 | CN1198583C Milling process for production of finely milled medicinal substances |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884807 3-bicyclic carbocyclic group substituted quinuclidine derivatives, which are cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptor and transporters |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884803 Phenylalkynes |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884794 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 04/26/2005 | US6884773 Modified hemoglobins, including nitrosylhemoglobins, and uses thereof |
| 04/26/2005 | US6884574 Methods of identifying agents which inhibit GPR-9-6 |
| 04/26/2005 | US6883516 Preparing solution of first component in liquid component such that after volatilization of liquid by passing solution through flow passage while heating, aerosol is formed having predetermined particle size distribution of first component |
| 04/26/2005 | CA2239053C Diphenyl pyridyl ethane derivatives as pde iv inhibitors |
| 04/26/2005 | CA2165830C Salmeterol xinafoate with controlled particle size |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035534A1 Heterocyclic bicyclo ring and heterocyclic tricyclo ring compounds and drugs comprising the same |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035471A1 Ether derivative |
| 04/21/2005 | WO2005034966A1 Use of xenon with hypothermia for treating neonatal asphyxia |
| 04/21/2005 | WO2005034929A2 Tissue remodeling and vascularization |
| 04/21/2005 | WO2005018529A3 Phenoxiacetic acid derivatives |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 04/21/2005 | US20050085758 Dilute aqueous solution containing epidermal growth factor in gel |
| 04/21/2005 | US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents |
| 04/21/2005 | US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders |
| 04/21/2005 | US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085505 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 04/21/2005 | US20050085471 Using 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-one; enzyme inhibitors; antithrombotic agents ; restenosis; atherosclerosis; antihistamines; chronic obsessive pulminary disease; autoimmune diseases; anticancer agents; antiinflammatory agents |
| 04/21/2005 | US20050085469 Fused bicyclic pyrimidine derivatives |
| 04/21/2005 | US20050085424 Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof |
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
| 04/21/2005 | US20050084552 Pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof |